ARDUAN Drug Patent Profile
✉ Email this page to a colleague
When do Arduan patents expire, and what generic alternatives are available?
Arduan is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in ARDUAN is pipecuronium bromide. There is one drug master file entry for this compound. Additional details are available on the pipecuronium bromide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARDUAN?
- What are the global sales for ARDUAN?
- What is Average Wholesale Price for ARDUAN?
Summary for ARDUAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Patent Applications: | 703 |
| DailyMed Link: | ARDUAN at DailyMed |
US Patents and Regulatory Information for ARDUAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | ARDUAN | pipecuronium bromide | INJECTABLE;INJECTION | 019638-001 | Jun 26, 1990 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
